Meet the Fibrosis Innovators Shaping the Future of Antifibrotic Therapies
Take a look at the esteemed speaker faculty for the 9th Antifibrotic Drug Development Summit 2025, featuring 25+ luminaries from top pharmaceutical companies, biotech innovators, and leading academic institutions. These experts will share groundbreaking research, clinical insights, and strategic visions to accelerate fibrosis drug development:
Gary Sweeney
Scientific Advisory Board Member & Professor
Allysta Pharmaceuticals Inc. & York University
Kevin Hart
Associate Research Fellow, Scientific Director, Fibrosis Exploratory Biology and Drug Discovery Group
Pfizer
Professor Ardeshir Bayat
Director, Medical Research Council Laboratory, Division of Dermatology
University of Cape Town
Rui Wu
Chief Officer ,Senior Vice President & Head of Research & Preclinical ,Chemistry, Manufacturing & Controls
Graviton BioScience
Yury Popov
Co-Director, Pathogens Immunity & Inflammation Translational Hub & Associate Professor, Medicine
Beth Israel Deaconess Medical Center